Rituximab is a chimeric anti-CD20 monoclonal B cell–depleting antibody indicated for certain
hematologic malignancies and active rheumatoid arthritis with inadequate response to …

Background Exercise has been shown to improve many health outcomes and well-being of
people of all ages. Long-term studies in older adults are needed to confirm disability and …

Objectives There is a need for effective and safe treatment during pregnancy in women with
chronic inflammatory diseases. This study evaluated placental transfer of certolizumab pegol …

The prevalence of systemic lupus erythematosus (SLE) in the United States is not known.
The estimates that are available have been based on populations in small geographic areas …

Objective To estimate the national occurrence of pregnancies in women with systemic lupus
erythematosus (SLE) and rheumatoid arthritis (RA) and to compare pregnancy outcomes in …

OBJECTIVE: The purpose of this study was to describe the outcomes of a 10-year cohort of
pregnancies in patients with systemic lupus erythematosus and to evaluate clinical and …

OBJECTIVE: To determine the rates of reported non-melanoma skin cancer (NMSC) in a
large cohort of patients with rheumatoid arthritis (RA) in comparison to patients with …

BACKGROUND: Prior studies of the relationship of physical activity to osteoarthritis (OA) of
the knee have shown mixed results. The objective of this study was to determine if differences …

OBJECTIVE: To determine if anti-tumor necrosis factor (TNF) therapy (adalimumab) can safely
improve symptoms of erosive/inflammatory osteoarthritis (EOA). METHODS: This was an …

OBJECTIVE: Systemic sclerosis, primary pulmonary hypertension, and sickle cell disease
are uncommon vasculopathic diseases affecting women. We estimated the nationwide …